Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment

Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment

Background: Pain and its opioid treatments are complex measurable traits. Responses to morphine in terms of pain control is likely to be determined by many factors, including the underlying pain sensitivity of the patient, along with nature and extent of the painful process, concomitant medications...

Full description

Bibliographic Details
Main Authors: Imen CHATTI, Jean-Baptiste WOILLARD, Amira MILI, Isabelle CREVEAUX, Ilhem BEN CHARFEDDINE, Jihène FEKI, Sarah LANGLAIS, Leila BEN FATMA, Ali SAAD, Moez GRIBAA, Frédéric LIBERT
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-11-01
Series:Iranian Journal of Public Health
Subjects:
Polymorphism
OPRM1
OPRK1
COMT
Cancer pain
Genetic heterogeneity
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/11769

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/11769

Similar Items